Director of Research  Position

NovaSterilis Incorporated is a rapidly growing, business located in Central New York near Cornell University. 

NovaSterilis is leading the way in improving the safety of the nations musculoskeletal human tissue supply. We currently have a Director of Research position available immediately.

Candidate to study the efficacy of our patented CO2 sterilization process and its subsequent effects on donor musculoskeletal tissue, engineered tissue and bioengineered materials. Manage and oversee the development and submission of independent research projects and conduct needs assessments; oversee data collection, input, and analysis, and evaluate program activities for proposal submissions. Additional duties include developing and implementing strategic grants with multiple projects, as well as coordinating the renewal of existing award applications, identifying and pursuing new and relevant grant opportunities, staying abreast of and interpreting grant management rules and regulations.

Applicants will a have PhD and 6-7 years of significant experience with biological and microbiology techniques, virology, and biomechanical testing.  Successful candidates will be experienced in management and driven to complete and succeed in project goals under deadline pressures.  Experience in writing federal grant applications and obtaining federal grant funding is required.  Position requires the ability to organize, analyze and interpret complex medical, scientific and/or technical data and write clear, cogent communications.  Excellent verbal and written communication skills, as well as exceptional interpersonal communications skills are also required.

Salary will be commensurate with experience.

Please send a letter of interest with research experience and salary requirements along with resume to:

Barbara Policay
NovaSterilis Inc.

3109 N. Triphammer Road
Lansing, NY 14882
E-mail: bsp1@novasterilis.com

To apply: send resume with cover letter to bsp1@novasterilis.com

NovaSterilis is committed to providing a new level of patient safety and product performance through the development of a new, emerging technology. The development of the supercritical carbon dioxide as a solvent for the NovaKill sterilent allows the biomedical community to achieve sterilization without compromising the product's integrity. We have developed and preformed countless tests and experiments specifically designed to prove the existence of a Sterility Assurance Level of (SAL6) and the ease with which it is achieved. We are authorized to commercialize and sell this techology to various businesses including tissue bank processors